| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |